000566 海南海药
已收盘 09-08 15:00:00
资讯
新帖
简况
海南海药（000566）披露2026年半年度报告，8月31日股价下跌1.79%
证券之星 · 08-31
海南海药（000566）披露2026年半年度报告，8月31日股价下跌1.79%
海南海药（000566）2026年中报简析：净利润同比下降33.97%，三费占比上升明显
证券之星 · 08-30
海南海药（000566）2026年中报简析：净利润同比下降33.97%，三费占比上升明显
海南海药(000566)6月30日股东户数12.66万户，较上期增加12.22%
证券之星 · 08-29
海南海药(000566)6月30日股东户数12.66万户，较上期增加12.22%
图解海南海药中报：第二季度单季净利润同比下降50.80%
证券之星 · 08-29
图解海南海药中报：第二季度单季净利润同比下降50.80%
股市必读：海南海药（000566）8月21日董秘有最新回复
证券之星 · 08-24
股市必读：海南海药（000566）8月21日董秘有最新回复
海南海药：解决同业竞争事关公司规范治理与长远未来
证券之星 · 08-21
海南海药：解决同业竞争事关公司规范治理与长远未来
海南海药：氟非尼酮III期临床及派恩加滨IIb期临床试验正在积极有序推进
证券之星 · 08-21
海南海药：氟非尼酮III期临床及派恩加滨IIb期临床试验正在积极有序推进
海南海药（000566）披露涉及诉讼的公告，8月14日股价下跌4.22%
证券之星 · 08-14
海南海药（000566）披露涉及诉讼的公告，8月14日股价下跌4.22%
7月31日海南海药（000566）龙虎榜数据：机构净买入6771.65万元，北向资金净买入1954.0万元
证券之星 · 07-31
7月31日海南海药（000566）龙虎榜数据：机构净买入6771.65万元，北向资金净买入1954.0万元
异动快报：海南海药（000566）7月30日9点54分触及涨停板
证券之星 · 07-30
异动快报：海南海药（000566）7月30日9点54分触及涨停板
7月28日海南海药（000566）龙虎榜数据：北向资金净买入3597.72万元（3日）
证券之星 · 07-28
7月28日海南海药（000566）龙虎榜数据：北向资金净买入3597.72万元（3日）
异动快报：海南海药（000566）7月28日9点31分触及涨停板
证券之星 · 07-28
异动快报：海南海药（000566）7月28日9点31分触及涨停板
海南海药：氟非尼酮III期已制定研发进度计划
证券之星 · 07-24
海南海药：氟非尼酮III期已制定研发进度计划
海南海药：员工规模变动系战略优化阶段性结果
证券之星 · 07-24
海南海药：员工规模变动系战略优化阶段性结果
海南海药：罗沙司他、小柴胡颗粒新增纳入新版国家基本药物目录
证券之星 · 07-24
海南海药：罗沙司他、小柴胡颗粒新增纳入新版国家基本药物目录
海南海药：公司2026年半年度报告全文的预约披露日期为2026年8月22日
证券之星 · 07-24
海南海药：公司2026年半年度报告全文的预约披露日期为2026年8月22日
海南海药：具体您可查阅公司披露的2025年年度报告第三节管理层讨论与分析之十一、公司未来发展的展望
证券之星 · 07-24
海南海药：具体您可查阅公司披露的2025年年度报告第三节管理层讨论与分析之十一、公司未来发展的展望
海南海药：公司高度重视创新药的研发工作
证券之星 · 07-24
海南海药：公司高度重视创新药的研发工作
公司问答丨海南海药：创新药氟非尼酮III期已制定研发进度计划 目前已开始III期临床相关前期工作 派恩加滨IIb期正积极推进
格隆汇 · 07-21
公司问答丨海南海药：创新药氟非尼酮III期已制定研发进度计划 目前已开始III期临床相关前期工作 派恩加滨IIb期正积极推进
7月17日海南海药（000566）龙虎榜数据：机构净买入2168.47万元，北向资金净卖出5163.68万元
证券之星 · 07-17
7月17日海南海药（000566）龙虎榜数据：机构净买入2168.47万元，北向资金净卖出5163.68万元
加载更多
公司概况
公司名称：
海南海药股份有限公司
所属行业：
医药制造业
上市日期：
1994-05-25
主营业务：
海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是抗生素系列、胃肠道用药系列、抗肿瘤药系列、与制剂配套的原料药和中间体系列。
发行价格：
5.80
{"stockData":{"symbol":"000566","market":"SZ","secType":"STK","nameCN":"海南海药","latestPrice":4.99,"timestamp":1788850983000,"preClose":4.92,"halted":0,"volume":67003300,"delay":0,"changeRate":0.0142,"floatShares":1297000000,"shares":1297000000,"eps":-0.3729,"marketStatus":"已收盘","change":0.07,"latestTime":"09-08 15:00:00","open":4.92,"high":5.03,"low":4.86,"amount":333000000,"amplitude":0.0346,"askPrice":5,"askSize":8813,"bidPrice":4.99,"bidSize":3916,"shortable":0,"etf":0,"ttmEps":-0.3729,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788917400000},"marketStatusCode":5,"adr":0,"adjPreClose":4.92,"symbolType":"stock","openAndCloseTimeList":[[1788831000000,1788838200000],[1788843600000,1788850800000]],"highLimit":5.41,"lowLimit":4.43,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1297365126,"isCdr":false,"pbRate":-48.41,"roa":"--","roe":"0.0%","epsLYR":-0.3314,"committee":-0.141229,"marketValue":6474000000,"turnoverRate":0.0517,"status":0,"floatMarketCap":6470000000},"requestUrl":"/m/hq/s/000566","defaultTab":"news","newsList":[{"id":"2663071812","title":"海南海药（000566）披露2026年半年度报告，8月31日股价下跌1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071812","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663071812?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:48","pubTimestamp":1788169703,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，海南海药报收于4.95元，较前一交易日下跌1.79%，最新总市值为64.22亿元。近日，海南海药股份有限公司披露《2026年半年度报告》。报告期末普通股股东总数为126,648户。公司控股股东及实际控制人在报告期内未发生变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100025188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0060","BK0188","BK0146","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663246048","title":"海南海药（000566）2026年中报简析：净利润同比下降33.97%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2663246048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663246048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:20","pubTimestamp":1788042022,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海南海药发布2026年中报。截至本报告期末，公司营业总收入3.21亿元，同比下降28.65%，归母净利润-2.12亿元，同比下降33.97%。本报告期海南海药三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达44.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012608","title":"海南海药(000566)6月30日股东户数12.66万户，较上期增加12.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012608","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012608?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:12","pubTimestamp":1787994732,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海南海药披露，截至2026年6月30日公司股东户数为12.66万户，较3月31日增加1.38万户，增幅为12.22%。在化学制药行业个股中，海南海药股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年3月31日至2026年6月30日，海南海药区间跌幅为8.27%，在此期间股东户数增加1.38万户，增幅为12.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0070","BK0146","BK0060","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018461","title":"图解海南海药中报：第二季度单季净利润同比下降50.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018461","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663018461?lang=zh_cn&edition=full","pubTime":"2026-08-29 02:31","pubTimestamp":1787941919,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药2026年中报显示，上半年度公司主营收入3.21亿元，同比下降28.65%；归母净利润-2.12亿元，同比下降33.97%；扣非净利润-2.52亿元，同比下降39.73%；其中2026年第二季度，公司单季度主营收入1.53亿元，同比下降37.18%；单季度归母净利润-1.36亿元，同比下降50.8%；单季度扣非净利润-1.51亿元，同比下降48.29%；负债率101.87%，投资收益-449.33万元，财务费用8468.32万元，毛利率18.24%。财报数据概要请见下图:本文数据来源于海南海药2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900006109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661243784","title":"股市必读：海南海药（000566）8月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2661243784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661243784?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:04","pubTimestamp":1787504652,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，海南海药报收于4.84元，下跌6.56%，换手率8.82%，成交量114.37万手，成交额5.53亿元。当日关注点交易信息汇总：8月21日主力资金净流出3587.67万元，占总成交额6.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0188","BK0060","BK0146","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298732","title":"海南海药：解决同业竞争事关公司规范治理与长远未来","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661298732?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:52","pubTimestamp":1787316743,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药08月21日在投资者关系平台上答复投资者关心的问题。公司将全力加快事项推进解决，以实实在在的行动推进各项工作，维护股东长远利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100043011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0070","BK0146","BK0060","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661987632","title":"海南海药：氟非尼酮III期临床及派恩加滨IIb期临床试验正在积极有序推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2661987632","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661987632?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:52","pubTimestamp":1787316739,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)08月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，董事长及海药管理层，贵公司创新药进展一直为业内所诟病，进度缓慢？请问管理层对于创新药进展有没有督促管理方案？海南海药回复：您好，公司紧盯创新药核心突破，持续加码两款创新药研发投入，全速推进临床试验进程，氟非尼酮III期临床及派恩加滨IIb期临床试验正在积极有序推进。公司将根据进展情况及时履行信息披露义务，敬请广大投资者注意投资风险。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100043006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0239","BK0070","000566","BK0060","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659800147","title":"海南海药（000566）披露涉及诉讼的公告，8月14日股价下跌4.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659800147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659800147?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:06","pubTimestamp":1786716399,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，海南海药报收于5.45元，较前一交易日下跌4.22%，最新总市值为70.71亿元。该股当日开盘5.62元，最高5.73元，最低5.36元，成交额达8.69亿元，换手率为12.22%。近日，海南海药股份有限公司及全资子公司海口市制药厂有限公司作为被告，收到海口市秀英区人民法院送达的《应诉通知书》。法院已受理，尚未开庭审理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400039618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0146","BK0188","BK0070","BK0060","000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655354288","title":"7月31日海南海药（000566）龙虎榜数据：机构净买入6771.65万元，北向资金净买入1954.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2655354288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655354288?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:40","pubTimestamp":1785490857,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月31日公布的交易公开信息显示，海南海药因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年7月31日收盘，海南海药报收于5.86元，下跌1.51%，换手率25.55%，成交量331.33万手，成交额19.11亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入6771.65万元，北向资金合计净买入1954.0万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100029714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0060","BK0188","000566","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655849858","title":"异动快报：海南海药（000566）7月30日9点54分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2655849858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655849858?lang=zh_cn&edition=full","pubTime":"2026-07-30 10:01","pubTimestamp":1785376891,"startTime":"0","endTime":"0","summary":"证券之星7月30日盘中消息，9点54分海南海药（000566）触及涨停板。其所属行业化学制药目前上涨。领涨股为海南海药。该股为海南自由贸易港，海南概念，自由贸易港概念热股，当日海南自由贸易港概念上涨2.58%，海南概念概念上涨2.21%，自由贸易港概念上涨2.03%。7月29日的资金流向数据方面，主力资金净流出869.69万元，占总成交额0.62%，游资资金净流出9693.1万元，占总成交额6.92%，散户资金净流入1.06亿元，占总成交额7.54%。近5日资金流向一览见下表：海南海药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000009435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","000566","BK0239","BK0146","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654008590","title":"7月28日海南海药（000566）龙虎榜数据：北向资金净买入3597.72万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2654008590","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654008590?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:48","pubTimestamp":1785232133,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月28日公布的交易公开信息显示，海南海药因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月28日收盘，海南海药报收于5.83元，上涨10.0%，已连续涨停2天，换手率6.22%，成交量80.71万手，成交额4.64亿元。从龙虎榜公布的三日买卖数据来看，北向资金合计净买入3597.72万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800029157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000566","BK0060","BK0146","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654012024","title":"异动快报：海南海药（000566）7月28日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2654012024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654012024?lang=zh_cn&edition=full","pubTime":"2026-07-28 09:40","pubTimestamp":1785202850,"startTime":"0","endTime":"0","summary":"证券之星7月28日盘中消息，9点31分海南海药（000566）触及涨停板。其所属行业化学制药目前上涨。领涨股为海南海药。该股为脑科学，医疗信息化，自由贸易港概念热股，当日脑科学概念上涨1.25%，医疗信息化概念上涨1.14%，自由贸易港概念上涨1.03%。7月27日的资金流向数据方面，主力资金净流入2.43亿元，占总成交额55.01%，游资资金净流出9492.19万元，占总成交额21.46%，散户资金净流出1.48亿元，占总成交额33.55%。近5日资金流向一览见下表：海南海药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800009334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0146","BK0060","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653820980","title":"海南海药：氟非尼酮III期已制定研发进度计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2653820980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653820980?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:52","pubTimestamp":1784897565,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，氟非尼酮三期临床获许试验已于6月1日在CDE公示，所有法定手续已完备，请告知目前未披露里程碑（首例患者入组）的原因？预计什么时候实现FPI？海南海药回复：您好，公司始终重视创新药研发工作，氟非尼酮III期已制定研发进度计划，正在积极有序推进，目前已开始III期临床相关前期工作，公司将根据进展情况及时履行信息披露义务，敬请广大投资者注意投资风险。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0188","BK0146","000566","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653082086","title":"海南海药：员工规模变动系战略优化阶段性结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2653082086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653082086?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:52","pubTimestamp":1784897565,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药07月24日在投资者关系平台上答复投资者关心的问题。是市场需求、业务调整的影响，还是技术迭代、成本变动，抑或是内部管理优化导致的？未来一年员工规模还会继续缩减吗？公司将持续执行“总量平稳、结构优化、提质增效”的人力资源战略。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0060","BK0239","000566","BK0146","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653060082","title":"海南海药：罗沙司他、小柴胡颗粒新增纳入新版国家基本药物目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2653060082","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653060082?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:52","pubTimestamp":1784897565,"startTime":"0","endTime":"0","summary":"公司有多个品种纳入国家基本药物目录，本次新增纳入新版国家基本药物目录产品为罗沙司他、小柴胡颗粒。罗沙司他作为本次新增的血液系统用药，小柴胡颗粒作为新增中成药品种，均为首次进入基药目录。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0188","BK0146","000566","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653082725","title":"海南海药：公司2026年半年度报告全文的预约披露日期为2026年8月22日","url":"https://stock-news.laohu8.com/highlight/detail?id=2653082725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653082725?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:52","pubTimestamp":1784897564,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：半年度业绩什么时候公布？海南海药回复：您好，公司已在巨潮资讯网披露了《2026 年半年度业绩预告》。公司2026年半年度报告全文的预约披露日期为2026年8月22日，届时请留意公司公告。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","000566","BK0060","BK0239","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653308273","title":"海南海药：具体您可查阅公司披露的2025年年度报告第三节管理层讨论与分析之十一、公司未来发展的展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2653308273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653308273?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:52","pubTimestamp":1784897563,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，新兴际华集团是曾经的世界500强，目前旗下三家上市公司：兴新铸管，际华集团，海南海药。其中海药营收和另外两家偏离巨大，集团也曾定位医药板块是公司发展新的增长极，请问公司十五五期间如何提升营收？有何战略发展规划？海南海药回复：您好，具体您可查阅公司披露的2025年年度报告第三节管理层讨论与分析之十一、公司未来发展的展望。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0060","BK0188","BK0239","BK0070","000566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653108270","title":"海南海药：公司高度重视创新药的研发工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2653108270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653108270?lang=zh_cn&edition=full","pubTime":"2026-07-24 20:52","pubTimestamp":1784897563,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：海药获国资大力扶持，又获国家创新药板块持续投入，理应一片大好的！海南海药回复：您好，公司高度重视创新药的研发工作，正在积极推进创新药临床试验各项工作，如有新进展公司将根据规定履行信息披露义务，感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400039699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0070","BK1574","000566","BK0239","159992","BK0188","BK1161","06978","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653273144","title":"公司问答丨海南海药：创新药氟非尼酮III期已制定研发进度计划 目前已开始III期临床相关前期工作 派恩加滨IIb期正积极推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2653273144","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653273144?lang=zh_cn&edition=full","pubTime":"2026-07-21 17:40","pubTimestamp":1784626804,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159992","000566","BK0188","BK0070","BK0239","BK0060","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652401767","title":"7月17日海南海药（000566）龙虎榜数据：机构净买入2168.47万元，北向资金净卖出5163.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652401767","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652401767?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:45","pubTimestamp":1784281542,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月17日公布的交易公开信息显示，海南海药因日振幅值达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年7月17日收盘，海南海药报收于5.1元，下跌10.05%，跌停，换手率23.89%，成交量309.79万手，成交额17.04亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入2168.47万元，北向资金合计净卖出5163.68万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700032768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","000566","BK0060","BK0188","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788911675775,"stockEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":-0.1669},{"period":"3month","weight":0.2961},{"period":"6month","weight":-0.1121},{"period":"1year","weight":-0.1725},{"period":"ytd","weight":-0.3021}],"compareEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":0.0001},{"period":"3month","weight":-0.0132},{"period":"6month","weight":-0.0457},{"period":"1year","weight":0.0297},{"period":"ytd","weight":-0.0071}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南海药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"126648人(较上一季度增加12.22%)","perCapita":"10238股","listingDate":"1994-05-25","address":"海南省海口市秀英区南海大道192号","registeredCapital":"129736万元","survey":" 海南海药股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是抗生素系列、胃肠道用药系列、抗肿瘤药系列、与制剂配套的原料药和中间体系列。","listedPrice":5.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海南海药,000566,海南海药股票,海南海药股票老虎,海南海药股票老虎国际,海南海药行情,海南海药股票行情,海南海药股价,海南海药股市,海南海药股票价格,海南海药股票交易,海南海药股票购买,海南海药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}